Can Moderna turn hantavirus urgency into a credible rare-virus vaccine strategy?
Moderna surged on hantavirus hopes. The real test is whether rare-virus urgency can become a viable mRNA vaccine pathway.
Moderna surged on hantavirus hopes. The real test is whether rare-virus urgency can become a viable mRNA vaccine pathway.
Evaxion A/S unveils AI-designed polio vaccine concepts with eradication potential. Read what this means for vaccine innovation and platform risk.